Credit Suisse’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-6,869
| Closed | -$327K | – | 3102 |
|
|
2023
Q3 | $327K | Sell |
6,869
-1,670
| -20% | -$79.5K | ﹤0.01% | 2893 |
|
|
2023
Q2 | $818K | Buy |
8,539
+2,399
| +39% | +$230K | ﹤0.01% | 2512 |
|
|
2023
Q1 | $696K | Buy |
6,140
+2
| +0% | +$227 | ﹤0.01% | 2525 |
|
|
2022
Q4 | $687K | Buy |
6,138
+307
| +5% | +$34.4K | ﹤0.01% | 2571 |
|
|
2022
Q3 | $749K | Buy |
5,831
+1,313
| +29% | +$169K | ﹤0.01% | 2513 |
|
|
2022
Q2 | $309K | Buy |
4,518
+177
| +4% | +$12.1K | ﹤0.01% | 3128 |
|
|
2022
Q1 | $618K | Buy |
4,341
+188
| +5% | +$26.8K | ﹤0.01% | 2831 |
|
|
2021
Q4 | $692K | Buy |
4,153
+1,830
| +79% | +$305K | ﹤0.01% | 2826 |
|
|
2021
Q3 | $323K | Buy |
2,323
+182
| +9% | +$25.3K | ﹤0.01% | 3227 |
|
|
2021
Q2 | $1.02M | Sell |
2,141
-255
| -11% | -$121K | ﹤0.01% | 2616 |
|
|
2021
Q1 | $987K | Sell |
2,396
-3,430
| -59% | -$1.41M | ﹤0.01% | 2588 |
|
|
2020
Q4 | $2.85M | Buy |
+5,826
| New | +$2.85M | ﹤0.01% | 1910 |
|
|
2018
Q2 | – | Sell |
-704
| Closed | -$103K | – | 3545 |
|
|
2018
Q1 | $103K | Buy |
704
+180
| +34% | +$26.3K | ﹤0.01% | 3369 |
|
|
2017
Q4 | $106K | Sell |
524
-519
| -50% | -$105K | ﹤0.01% | 3333 |
|
|
2017
Q3 | $334K | Buy |
1,043
+480
| +85% | +$154K | ﹤0.01% | 3210 |
|
|
2017
Q2 | $127K | Buy |
+563
| New | +$127K | ﹤0.01% | 3309 |
|
|
2017
Q1 | – | Sell |
-1,405
| Closed | -$279K | – | 3532 |
|
|
2016
Q4 | $279K | Buy |
1,405
+118
| +9% | +$23.4K | ﹤0.01% | 3332 |
|
|
2016
Q3 | $317K | Buy |
1,287
+487
| +61% | +$120K | ﹤0.01% | 3298 |
|
|
2016
Q2 | $465K | Buy |
800
+320
| +67% | +$186K | ﹤0.01% | 3171 |
|
|
2016
Q1 | $254K | Buy |
480
+48
| +11% | +$25.4K | ﹤0.01% | 3291 |
|
|
2015
Q4 | $303K | Sell |
432
-1,027
| -70% | -$720K | ﹤0.01% | 3457 |
|
|
2015
Q3 | $865K | Buy |
+1,459
| New | +$865K | ﹤0.01% | 2752 |
|